HLVX
Income statement / Annual
Last year (2024), HilleVax, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, HilleVax, Inc.'s net income was -$147.27 M.
See HilleVax, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$2.16 M
|
$2.25 M
|
$3.00 K
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
-$2.16 M
|
-$2.25 M
|
-$3.00 K
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$78.17 M
|
$106.68 M
|
$45.91 M
|
$10.01 M
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$28.79 M
|
$26.66 M
|
$16.71 M
|
$5.76 M
|
$1.30 M
|
$633.00 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$28.79 M
|
$26.66 M
|
$16.71 M
|
$5.76 M
|
$1.30 M
|
$633.00 K
|
| Other Expenses |
$48.33 M
|
$0.00
|
-$94.70 M
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$155.29 M
|
$133.35 M
|
$62.61 M
|
$15.77 M
|
$1.30 M
|
$633.00 K
|
| Cost And Expenses |
$0.00
|
$133.35 M
|
$62.61 M
|
$15.77 M
|
$1.30 M
|
$633.00 K
|
| Interest Income |
$7.05 M
|
$9.71 M
|
$3.88 M
|
$2.84 K
|
$29.00
|
$9.00
|
| Interest Expense |
-$3.32 M
|
$2.39 M
|
$3.41 M
|
$2.84 M
|
$29.00 K
|
$9.00 K
|
| Depreciation & Amortization |
$0.00
|
$879.00 K
|
$2.25 M
|
$3.00 K
|
$1.30 M
|
$633.00 K
|
| EBITDA |
-$155.29 M |
-$132.47 M |
-$65.11 M |
-$99.56 M |
-$779.00 K |
-$31.00 K |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$8.02 M
|
$9.78 M
|
-$94.70 M
|
-$48.98 M
|
-$808.00 K
|
-$40.00 K
|
| Income Before Tax |
-$147.27 M
|
-$123.57 M
|
-$159.81 M
|
-$102.41 M
|
-$2.10 M
|
-$673.00 K
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$147.27 M
|
-$123.57 M
|
-$257.01 M
|
-$85.03 M
|
-$2.13 M
|
-$673.00 K
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-3 |
-3.04 |
-6.83 |
-2.82 |
-0.0706 |
-0.0223 |
| EPS Diluted |
-3 |
-3.04 |
-6.83 |
-2.82 |
-0.0706 |
-0.0223 |
| Weighted Average Shares Out |
$49.15 M
|
$40.60 M
|
$37.66 M
|
$30.19 M
|
$30.19 M
|
$30.19 M
|
| Weighted Average Shares Out Diluted |
$49.15 M
|
$40.60 M
|
$37.66 M
|
$30.19 M
|
$30.19 M
|
$30.19 M
|
| Link |
|
|
|
|
|
|
